(PDF) Persistence and Failure Rates of Adalimumab

Persistence and Failure Rates of Adalimumab Monotherapy in Biologic-Naïve Patients With Psoriasis: A Retrospective Study

Journal of the American Academy of Dermatology - United States

doi 10.1016/j.jaad.2015.11.005

Full Text

Abstract

Available in full text

Categories

Date

March 1, 2016

Authors

Shivani P. Reddy

Publisher

Elsevier BV

Related search

Biologic Monotherapy in the Biologic Naïve Patient With Rheumatoid Arthritis (RA): Results From an Observational Study

Rheumatology International

English

Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?

Digestive Diseases and Sciences

Gastroenterology

English

Treatment Persistence in Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies

Value in Health

Occupational Health

English

Economic Evaluation of Tocilizumab Monotherapy vs Adalimumab Monotherapy in Patients With Rheumatoid Arthritis in Italy

Value in Health

Occupational Health

English

Long-Term Safety of Adalimumab in Adult Patients With Plaque Psoriasis

British Journal of Dermatology

English

Incidence of Pulmonary Arterial Hypertension in Patients With Psoriasis: A Retrospective Cohort Study

Permanente journal,The

English

Persistence With Antihypertensives in Uncomplicated Treatment-Naïve Very Elderly Patients: A Nationwide Population-Based Study

BMC Cardiovascular Disorders

Cardiovascular Medicine

English

Risk of Cancer in Patients With Psoriasis on Biologic Therapies: A Systematic Review

British Journal of Dermatology

English

Biologic Therapies in HIV-infected Patients With Psoriasis: An Italian Experience

Acta Dermato-Venereologica

English